Optometry in Practice (OiP), the College's quarterly CPD journal, covers the latest research, analysis and opinion from your profession, and provides up to 4 CPD points.
Investigating current practice for managing and treating AMD in Ireland and the UK.
Summary
Age-related macular degeneration (AMD) is the leading cause of blind registration in the western world, and the number of people with this condition continues to rise due to the ageing population. AMD destroys central vision and impairs quality of life in the elderly. Current treatment options, while effective in some patients, are costly and present a massive financial challenge for Europe and its healthcare services. There is a clear need, therefore, for attention to be directed towards the prevention or delay of AMD and its progression. The optometrist, who represents the first line of eye care, is uniquely placed to implement such a prevention strategy for AMD.
This paper reports and discusses findings from an online AMD research survey, designed to investigate current practice for AMD amongst optometric practitioners in the Republic of Ireland and the UK.
Sign in to continue
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
As age-related macular degeneration progresses, part of the visual cortex starts to atrophy. But which way does the causal relationship work, asks Kim Thomas, and what does it mean for treatments focused on the retina if the brain has entered an irreversible decline?
The effort, cost and logistics of managing treatment for eye conditions can have a big impact on patients’ quality of life. What can be done to minimise their treatment burden?